Salvia officinalis / LDL Cancer Research Results

Sage, Salvia officinalis: Click to Expand ⟱
Features:
Salvia officinalis(common sage) has been studied for its potential therapeutic effects in Alzheimer's disease (AD) and cancer due to its antioxidant, anti-inflammatory, neuroprotective, and anticancer properties.

Salvia officinalis — AD relevance: Sage has human clinical signals for cognition/AD, plausibly via cholinesterase inhibition plus anti-inflammatory/antioxidant support. Essential-oil chemotype matters for safety (thujone exposure).

Primary mechanisms (conceptual rank):
1) ↑ Cholinergic tone (AChE/BChE inhibition; symptomatic cognitive support)AChE ↓ → ACh ↑ (symptomatic cognitive enhancement)
2) ↓ Neuroinflammation (NF-κB/cytokine tone; model-supported)
3) ↓ Oxidative stress (↓ ROS/lipid peroxidation; stress-defense support)
4) Secondary network/synaptic efficiency effects (chronic adaptation)

Bioavailability / PK relevance: Oral leaf extracts used in trials; effects are typically over weeks–months. Avoid equating leaf extract with essential oil dosing due to thujone-associated neurotoxicity risk.

Clinical evidence status: Small double-blind RCT in mild–moderate AD (extract vs placebo) and additional placebo-controlled cognitive studies in non-AD populations; evidence is supportive but not definitive/disease-modifying.

-Sage contains compounds (e.g., rosmarinic acid, luteolin, carnosic acid) that inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).This enhances acetylcholine levels, supporting memory and cognition — similar to drugs like donepezil.
-High in phenolic compounds (e.g., flavonoids, diterpenes) that scavenge reactive oxygen species (ROS).

-High doses of thujone (a compound in some sage oils) may be neurotoxic or hepatotoxic.

Salvia officinalis — AD / Neurodegeneration Pathway Map

RankPathway / AxisCellsTSFPrimary EffectNotes / Interpretation
1 AChE ↓ → ACh ↑ (cholinergic synapse) ACh ↑ (via AChE inhibition) P/R Improved synaptic cholinergic transmission Extract inhibits acetylcholinesterase → reduced ACh breakdown → increased synaptic ACh. Symptomatic mechanism analogous to donepezil-class drugs.
2Neuroinflammation (NF-κB / cytokines) ↓R/G Reduced inflammatory stress Extracts show anti-inflammatory signaling in cell/biochemical models; relevance to AD progression is supportive.
3ROS / lipid peroxidation ↓P/R Oxidative burden reduction Phenolics/diterpenes contribute to antioxidant effects; typically requires sustained intake for tissue adaptation.
4NRF2 antioxidant-response program ↔ / ↑ (context-dependent)R/G Stress-defense regulation Consider as a supportive axis; not always directly measured in human cognition trials.
5Ca²⁺ excitotoxicity interplay ↔P/R Not primary More relevant to essential-oil neurotoxicity discussions than leaf-extract cognition trials; include only with explicit Ca²⁺ endpoints.
6Aβ / tau-associated pathology ↔ (limited human evidence)G Not established clinically Any anti-amyloid/tau claims are largely preclinical; avoid over-weighting without biomarker-confirmed replication.
7Clinical Translation Constraint ↓ (constraint)— Safety + product variability Essential oil/thujone can be pro-convulsant; regulators specify limits for thujone exposure in herbal products. Extract standardization and duration (weeks–months) matter.

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr
LDL, LDL-cholesterol: Click to Expand ⟱
Source:
Type:
The relationship between LDL (low-density lipoprotein) cholesterol and cancer is a complex and evolving area of research. LDL cholesterol is often referred to as "bad" cholesterol because high levels are associated with an increased risk of cardiovascular diseases.

Protumorigenic: High levels of LDL cholesterol can promote tumor growth by providing lipids that are essential for cell membrane synthesis and energy production. Additionally, LDL can influence inflammation and angiogenesis, further supporting tumor development.
Antitumorigenic: Some studies suggest that lowering LDL cholesterol through lifestyle changes or medications (like statins) may have a protective effect against certain cancers, although the evidence is not uniform across all cancer types.
Scientific Papers found: Click to Expand⟱
3639- Sage,    Pharmacological properties of Salvia officinalis and its components
- Review, AD, NA - Review, Var, NA
AntiCan↑, *Inflam↓, *antiOx↑, *cognitive↑, *memory↑, *LDL↓, TumCG↓, MAPK↓, ROS↓, NF-kB↓, COX2↓, angioG↓, *AST↓, *ALAT?,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress ⓘ

ROS↓, 1,  

Cell Death ⓘ

MAPK↓, 1,  

Proliferation, Differentiation & Cell State ⓘ

TumCG↓, 1,  

Angiogenesis & Vasculature ⓘ

angioG↓, 1,  

Immune & Inflammatory Signaling ⓘ

COX2↓, 1,   NF-kB↓, 1,  

Functional Outcomes ⓘ

AntiCan↑, 1,  
Total Targets: 7

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress ⓘ

antiOx↑, 1,  

Core Metabolism/Glycolysis ⓘ

ALAT?, 1,   LDL↓, 1,  

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,  

Clinical Biomarkers ⓘ

ALAT?, 1,   AST↓, 1,  

Functional Outcomes ⓘ

cognitive↑, 1,   memory↑, 1,  
Total Targets: 8

Scientific Paper Hit Count for: LDL, LDL-cholesterol
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:338  Target#:71  State#:%  Dir#:%
  wNotes=0  sortOrder:rid,rpid

 

Home Page